Search results
Results from the Think 24/7 Content Network
Amlodipine/valsartan, sold under the brand name Exforge among others, is a blood pressure lowering combination drug. It contains amlodipine, as the besilate, a dihydropyridine -type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist. [3] This combination is usually well tolerated and effective for the reduction of ...
Valsartan. Valsartan, sold under the brand name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. [8] It belongs to a class of medications referred to as angiotensin II receptor blockers (ARBs). It is a reasonable initial treatment for high blood pressure. [8]
Valsartan/hydrochlorothiazide, sold under the brand name Diovan HCT among others, is a medication used to treat high blood pressure when valsartan is not sufficient. It is a combination of valsartan, an angiotensin receptor blocker with hydrochlorothiazide, a diuretic. It is taken by mouth. Common side effects include dizziness and headaches.
The researchers suggested either diet or long-term supplementation. According to another review in Cureus, omega-3s improved memory, cognitive well-being, and blood flow in the brain. These ...
June 20, 2024 at 1:25 PM. (Reuters) - The World Health Organization on Thursday issued warnings on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug ...
Overstock.com, a discount furniture site, is now fully operating under BedBathandBeyond.com, offering an expanded range of categories, including bedding, bath, kitchen, and even kids and babies.
Sacubitril/valsartan, sold under the brand name Entresto, is a fixed-dose combination medication for use in heart failure. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan. The combination is sometimes described as an "angiotensin receptor-neprilysin inhibitor" (ARNi). [9]
Overstock.com, launched in 1999 as a liquidator and gone public in 2002, saw quarterly net revenues decline 20% year-on-year last quarter to $422 million. The company had a net quarterly loss of ...